| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | US7205310 inflammatory conditions such as multiple sclerosis |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205299 Indole derivatives having an apoptosis-inducing effect |
| 04/17/2007 | US7205298 Substituted triazine kinase inhibitors |
| 04/17/2007 | US7205293 Benodiazepine spirohydantoin CGRP receptor antagonists |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors |
| 04/17/2007 | CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 04/12/2007 | WO2007041634A1 Pyrimidine amide compounds as pgds inhibitors |
| 04/12/2007 | WO2007041358A2 Substituted pyrazole compounds |
| 04/12/2007 | WO2007041357A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040440A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040436A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007039821A2 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039581A1 Imidazolyl-substituted diazabenzophenone compounds |
| 04/12/2007 | WO2007039580A1 Imidazolyl-substituted benzophenone compounds |
| 04/12/2007 | WO2007039499A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 04/12/2007 | WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/12/2007 | WO2007039404A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
| 04/12/2007 | WO2007039146A1 4-carboxy pyrazole derivatives as anti-viral agents |
| 04/12/2007 | WO2007039117A2 A process for the preparation of sartan derivatives and intermediates useful in such process |
| 04/12/2007 | WO2007012670A3 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists |
| 04/12/2007 | WO2007009720A3 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/12/2007 | WO2007009711A3 Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082932 Pyrrolidine compounds |
| 04/12/2007 | US20070082929 Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties |
| 04/12/2007 | US20070082927 Piperidine derivative having nmda receptor antagonistic activity |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082913 Substituted heterocyclic compounds with CXCR3 antagonist activity |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082907 Peroxisome proliferator activated receptor modulators |
| 04/12/2007 | US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma |
| 04/12/2007 | US20070082904 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention |
| 04/12/2007 | US20070082899 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082894 Pyrazine-based tubulin inhibitors |
| 04/12/2007 | US20070082892 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands |
| 04/12/2007 | US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes |
| 04/12/2007 | US20070082067 2-[4-(3-Methoxy-4-pyridin-2-ylphenyl)-2H-1,2,3-triazol-2-yl]pyridine; psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders |
| 04/12/2007 | US20070080630 Such as 4-tert-butyl-4'-[N-(9-phenylcarbazol-3-yl)-N-phenylamino]stilbene; thinness, lightweight, and rapid response is expected to be applied to flat panel displays; excellent color purity of blue, luminous efficiency, durability |
| 04/12/2007 | CA2624875A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624020A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 04/12/2007 | CA2623822A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | CA2623348A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | CA2623154A1 Novel fused pyrrole derivative |
| 04/12/2007 | CA2622673A1 Sulphonylpyrroles and use thereof as inhibitors of hdac s |
| 04/12/2007 | CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/11/2007 | EP1771445A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 04/11/2007 | EP1771442A1 Viral polymerase inhibitors |
| 04/11/2007 | EP1771441A1 Novel carboxamides for use as xa inhibitors |
| 04/11/2007 | EP1771438A1 1-3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
| 04/11/2007 | EP1771422A1 Quinazolinone derivatives as parp inhibitors |
| 04/11/2007 | EP1771175A1 Phthalazine derivatives as parp inhibitors |
| 04/11/2007 | EP1694669B1 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions |
| 04/11/2007 | EP1678164B1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | EP1084107B1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 04/11/2007 | EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/11/2007 | CN1946715A Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 04/11/2007 | CN1946714A Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 04/11/2007 | CN1946703A Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| 04/11/2007 | CN1946701A Tri-substituted ureas as cytokine inhibitors |
| 04/11/2007 | CN1946700A Tri-substituted ureas as cytokine inhibitors |
| 04/11/2007 | CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins |
| 04/11/2007 | CN1946691A Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946686A Method for preparing pyrrolidine oximes |
| 04/11/2007 | CN1946397A Ion channel modulators |
| 04/11/2007 | CN1943577A Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202265 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
| 04/10/2007 | US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202244 Chk-1 inhibitors |
| 04/10/2007 | US7202237 Pyridylether derivatives, their preparation and use |
| 04/10/2007 | US7202232 Acrylonitrile derivatives for inflammation and immune-related uses |
| 04/10/2007 | US7202092 Activated haptens useful for generating immunogens to HIV protease inhibitors; reacting indinavir sulfate in the presence of hydrogen gas and palladium catalyst to form indinavir M6 |
| 04/10/2007 | US7202004 Electrophotographic organophotoreceptors with novel charge transport materials |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2273841C 3-thiocarbamoylpyrazole derivatives as pesticides |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |